Revision history of "Identification of biomarkers associated with the efficacy of treatment with biological medicinal products in patients with severe asthma." (Q3150755)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 09:2109:21, 11 October 2024DG Regio talk contribs 71,991 bytes +13 Set a claim value: summary (P836): A asma é uma doença inflamatória crónica que afeta atualmente 334 milhões de pessoas, causando uma morbilidade-mortalidade significativa e um enorme custo económico para o SNS. A maioria dos doentes diagnosticados com asma pode ser eficazmente tratada com corticosteroides inalados e broncodilatadores. Contudo, há um grupo de pacientes que não são controlados com este tratamento, pacientes com a asma descontrolada severa. Têm uma taxa de mortalidade...

7 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 22:2722:27, 17 August 2022DG Regio talk contribs 70,706 bytes +48,325 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 16:4716:47, 2 December 2021DG Regio talk contribs 14,842 bytes +2,383 Created claim: summary (P836): L’asthme est une maladie inflammatoire chronique qui touche actuellement 334 millions, causant une morbidité-mortalité importante et un coût économique énorme pour le SNS. La plupart des patients atteints d’asthme peuvent être traités efficacement par des corticostéroïdes et des bronchodilatateurs inhalés. Cependant, il existe un groupe de patients qui ne sont pas contrôlés par ce traitement, des patients atteints d’asthme sévère non contrôlé. I...
  • curprev 16:4716:47, 2 December 2021DG Regio talk contribs 12,459 bytes +215 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 15:2015:20, 12 October 2021DG Regio talk contribs 12,244 bytes +2,149 Created claim: summary (P836): Asthma is a chronic inflammatory disease that currently affects 334 million, causing a significant morbidity-mortality and enormous economic cost to the SNS. Most patients diagnosed with asthma can be effectively treated with inhaled corticosteroids and bronchodilators. However, there is a group of patients who are not controlled with this treatment, patients with severe uncontrolled asthma. They have a higher mortality rate and a high number of...
  • curprev 15:2015:20, 12 October 2021DG Regio talk contribs 10,095 bytes −2,149 Removed claim: summary (P836): Asthma is a chronic inflammatory disease that currently affects 334 million, causing a significant morbidity-mortality and enormous economic cost to the SNS. Most patients diagnosed with asthma can be effectively treated with inhaled corticosteroids and bronchodilators. However, there is a group of patients who are not controlled with this treatment, patients with severe uncontrolled asthma. They have a higher mortality rate and a high number...
  • curprev 15:0915:09, 12 October 2021DG Regio talk contribs 12,244 bytes +197 Changed label, description and/or aliases in en: translated_label
  • curprev 15:0915:09, 12 October 2021DG Regio talk contribs 12,047 bytes +2,149 Created claim: summary (P836): Asthma is a chronic inflammatory disease that currently affects 334 million, causing a significant morbidity-mortality and enormous economic cost to the SNS. Most patients diagnosed with asthma can be effectively treated with inhaled corticosteroids and bronchodilators. However, there is a group of patients who are not controlled with this treatment, patients with severe uncontrolled asthma. They have a higher mortality rate and a high number of...

10 October 2021

9 October 2021

8 October 2021